Marijuana Stocks News CLS Holdings USA, Inc. (CLSH) Discusses Growth Strategy and Significant Debt Reduction with The Stock Day Podcast CLS Holdings USA, Inc. Discusses Growth Strategy and Significant Debt Reduction with… Brett DavidJul 26, 2023
Marijuana Stocks News SOL Global Investments Corp. (SOLCF) Provides Interim Unaudited Financials for the Second Quarter Ended May 2023 SOL Global Provides Interim Unaudited Financials for the Second Quarter Ended May… J. SamuelJul 26, 2023
Marijuana Stocks News Canopy Growth Corporation (CGC) to Report First Quarter Fiscal 2024 Financial Results on August 9, 2023 Canopy Growth to Report First Quarter Fiscal 2024 Financial Results on August… Daniel ChaseJul 26, 2023
Featured Marijuana Trends & Articles These Marijuana Stocks Are Ready To Run In 2023 Top Marijuana Stocks To Buy Before Earnings? J. SamuelJul 26, 2023
Marijuana Stocks News TILT Holdings Inc. (TLLTF) Sets Second Quarter 2023 Conference Call for August 14 at 5:00 p.m. ET TILT Sets Second Quarter 2023 Conference Call for August 14 at 5:00… Daniel ChaseJul 25, 2023
Marijuana Stocks News Innocan Pharma Corporation (INNPF) Announces Private Placement of Units at a 9% Prime Above Share Price Innocan Pharma Announces Private Placement of Units at a 9% Prime Above… Daniel ChaseJul 25, 2023
Marijuana Stocks News SNDL Inc. (SNDL) and Nova Cannabis Extend Outside Date for Closing of the Strategic Partnership SNDL and Nova Cannabis Extend Outside Date for Closing of the Strategic… J. PhillipJul 25, 2023
Featured Marijuana Trends & Articles 3 Canadian Marijuana Stocks To Watch Today 2023 Investing In Cannabis 3 Canadian Marijuana Stocks To Know About J. PhillipJul 25, 2023
Marijuana Trends & Articles Diving into Green Investments: 3 US Marijuana Stocks Worth Monitoring Today Are These Pot Stocks On Your List This Week? Brett DavidJul 24, 2023
Marijuana Stocks News AbbVie Inc. (ABBV) Advances Immunology Pipeline with First Patient Dosed in Global Phase 3 Trial of Upadacitinib (RINVOQ®) AbbVie Advances Immunology Pipeline with First Patient Dosed in Global Phase 3… J. PhillipJul 24, 2023
